AzTrials
AzTrials

Strabismus; IntermittentNCT06543212

Eye Alignment and Eye Control Changes Through Follow up Period After Application of Eye Exercises Post Strabismus Surgery

An observational study of Strabismus; Intermittent, run by Amany Refaat Mohamed Abdel Wahid at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to determine the patient status through its follow up period and weather the eye alignment and eye control are as the same as the last physiotherapy treatment session or there is any deterioration of them. Read more about this study

Who is it for?
Ages 5 to 15 years
Conditions the study is for
Strabismus; Intermittent
What is being tested?
physiotherapy exercises
How many people
40 participants
Where
1 siteEgypt
Study dates
15 Aug 2024to 15 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: The population from both groups will be selected from Research Institute of Ophthalmology and completed physiotherapy training program for 3 months to improve eye alignment and eye control post strabismus surgery.

Who may be able to join

  • Patients are both males and females.
  • Their age will range from (5-15) years.
  • All Patients received physiotherapy training for improving eye alignment and eye control.
  • Patients applied the physiotherapy rehabilitation program for 3 months with the physiotherapist.
  • All Patients complete their physiotherapy training sessions for improving eye alignment and eye control
  • All Patients have a history of strabismus surgery.
  • Intermittent exotropia was the type of strabismus which included to the study.

Who cannot join

  • - Patient who didn't receive physiotherapy training program for improving eye control and eye alignment post strabismus surgery.
  • Patient who didn't complete the physiotherapy training program for 3 months.
  • Muscular disorders that will impair performance during training.
  • Any organic lesion in the eye.
  • Neurological disorders.
  • Malignant conditions.
  • Psychiatric illness, severe behavior or cognitive disorders.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Giza, Giza Governorate, 12613

Other trials in Egypt

About this study

The aim of this study is to determine the patient status through its follow up period and weather the eye alignment and eye control are as the same as the last physiotherapy treatment session or there is any deterioration of them.

Read the detailed description

This study is quantitative cohort observational study. The study depends on following a group of participants over a period of time ( 2 months after completed physiotherapy training program for 3 months to improve eye alignment and eye control post strabismus surgery ).

Through the study, there is observation to the changes in certain quantitative variables ( eye alignment and eye control ).

Being tested
physiotherapy exercises
Medical subject headings
Strabismus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • physiotherapy exercisesOther

    physiotherapy exercises to improve eye alignment and eye control post strabismus surgery

Study groups in NCT06543212
Study groupRoleWhat they receive
group continues with physiotherapyGroup continues with physiotherapy training in follow up period after last session of physiotherapy program post strabismus surgery.
Receives: Other: physiotherapy exercises
group doesn't continue with physiotherapyGroup doesn't continue with physiotherapy training in follow up period after last session of physiotherapy program post strabismus surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Eye deviation by prism-cover test

    This test is used to quantify the movement of deviating eye

    Measured: 3 months

  2. Measurement of eye control by Intermittent Exotropia Control Scale

    The level of control will be evaluated in each patient at both distance and near fixation using Intermittent Exotropia Control Scale. The scale ranges from 0 (phoria, best control) to 5 (constant exotropia, worst control).

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2024
  2. Study start15 Aug 2024
  3. Primary completion15 Dec 2024
  4. Study completion15 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06543212
Sponsor's protocol ID
P.T.REC/012/004678
Status last verified
Feb 2026
First submitted
4 Aug 2024
Last updated
23 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Strabismus; Intermittent, run by Amany Refaat Mohamed Abdel Wahid at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Eye deviation by prism-cover test (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in